jacqueline brown, Assistant Professor

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Astra Zeneca
    Topic:
    Muscle invasive bladder cancer
    Date added:
    03/06/2025
    Date updated:
    03/06/2025
    Relationship end date:
    03/06/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Xencor
    Topic:
    Kidney cancer
    Date added:
    03/06/2025
    Date updated:
    03/06/2025
    Relationship end date:
    03/06/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    EMD Serono
    Topic:
    Metastatic bladder cancer
    Date added:
    03/06/2025
    Date updated:
    03/06/2025
    Relationship end date:
    11/21/2024
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Exelixis
    Topic:
    Kidney cancer
    Date added:
    03/06/2025
    Date updated:
    03/06/2025
    Relationship end date:
    03/06/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Pfizer
    Topic:
    Metastatic bladder cancer
    Date added:
    03/06/2025
    Date updated:
    03/06/2025
    Relationship end date:
    12/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Medicenna
    Topic:
    Institutional research funding
    Date added:
    03/06/2025
    Date updated:
    03/06/2025
    Relationship end date:
    04/15/2026
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Merck Sharpe and Dohme
    Topic:
    Institutional research funding
    Date added:
    03/06/2025
    Date updated:
    03/06/2025
    Relationship end date:
    03/24/2027
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Pliant Therapeutics
    Topic:
    Institutional research funding
    Date added:
    03/06/2025
    Date updated:
    03/06/2025
    Relationship end date:
    03/23/2027
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Duality Biologics
    Topic:
    Institutional research funding
    Date added:
    03/06/2025
    Date updated:
    03/06/2025
    Relationship end date:
    03/24/2027
  • Attribution:
    Self
    Type of financial relationship:
    Financial Support
    Ineligible company:
    Hookipa
    Topic:
    Institutional research funding
    Date added:
    03/06/2025
    Date updated:
    03/06/2025
    Relationship end date:
    08/13/2024

Pages

Return to Atlanta Genitourinary Cancers Summit